BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 36514219)

  • 1. Brusatol attenuated proliferation and invasion induced by KRAS in differentiated thyroid cancer through inhibiting Nrf2.
    Gong Z; Xue L; Vlantis AC; van Hasselt CA; Chan JYK; Fang J; Wang R; Yang Y; Li D; Zeng X; Tong MCF; Chen GG
    J Endocrinol Invest; 2024 May; 47(5):1271-1280. PubMed ID: 38062319
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Repositioning of Montelukast to inhibit proliferation of mutated KRAS pancreatic cancer through a novel mechanism that interfere the binding between KRAS and GTP/GDP.
    Xia Y; Zhang S; Luo H; Wang Y; Jiang Y; Jiang J; Yuan S
    Eur J Pharmacol; 2023 Dec; 961():176157. PubMed ID: 37939992
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel MTORC2-AKT-ROS axis triggers mitofission and mitophagy-associated execution of colorectal cancer cells upon drug-induced activation of mutant KRAS.
    Iskandar K; Foo J; Liew AQX; Zhu H; Raman D; Hirpara JL; Leong YY; Babak MV; Kirsanova AA; Armand AS; Oury F; Bellot G; Pervaiz S
    Autophagy; 2024 Feb; ():1-24. PubMed ID: 38261660
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Suppression of the
    Di Giorgio E; Choudhary H; Ferino A; Cortolezzis Y; Dalla E; D'Este F; Comelli M; Rapozzi V; Xodo LE
    iScience; 2023 Dec; 26(12):108566. PubMed ID: 38144458
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting the KRAS G12D Mutant as Potential Therapy in Cancer.
    Kargbo RB
    ACS Med Chem Lett; 2021 Aug; 12(8):1212-1213. PubMed ID: 34413947
    [No Abstract]   [Full Text] [Related]  

  • 6. Metabolomic Approach to Identify Potential Biomarkers in KRAS-Mutant Pancreatic Cancer Cells.
    Kim B; Jung J
    Biomedicines; 2024 Apr; 12(4):. PubMed ID: 38672219
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Role of Oxidative Stress in Tumorigenesis and Progression.
    Li K; Deng Z; Lei C; Ding X; Li J; Wang C
    Cells; 2024 Mar; 13(5):. PubMed ID: 38474405
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of Hydrogen Sulfide in Oncological and Non-Oncological Disorders and Its Regulation by Non-Coding RNAs: A Comprehensive Review.
    Youness RA; Habashy DA; Khater N; Elsayed K; Dawoud A; Hakim S; Nafea H; Bourquin C; Abdel-Kader RM; Gad MZ
    Noncoding RNA; 2024 Jan; 10(1):. PubMed ID: 38250807
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel LINC00478 serves as a tumor suppressor in endometrial carcinoma progression.
    Feng Y; Dong Y; Rao B; Yu Y; Su W; Zeng J; Zhao E; Chen Y; Fang S; Zhou Y; Lu J; Qiu F
    J Cancer Res Clin Oncol; 2023 Nov; 149(16):14927-14940. PubMed ID: 37603104
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The GTPase KRAS suppresses the p53 tumor suppressor by activating the NRF2-regulated antioxidant defense system in cancer cells.
    Yang H; Xiang S; Kazi A; Sebti SM
    J Biol Chem; 2020 Mar; 295(10):3055-3063. PubMed ID: 32001619
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biological insights in non-small cell lung cancer.
    Rosell R; Jain A; Codony-Servat J; Jantus-Lewintre E; Morrison B; Ginesta JB; González-Cao M
    Cancer Biol Med; 2023 Jun; 20(7):500-18. PubMed ID: 37381723
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting KRAS for diagnosis, prognosis, and treatment of pancreatic cancer: Hopes and realities.
    Bournet B; Buscail C; Muscari F; Cordelier P; Buscail L
    Eur J Cancer; 2016 Feb; 54():75-83. PubMed ID: 26735353
    [TBL] [Abstract][Full Text] [Related]  

  • 13. KRAS G12D mutation eliminates reactive oxygen species through the Nrf2/CSE/H
    Fan K; Zhang S; Ni X; Shen S; Wang J; Sun W; Suo T; Liu H; Ni X; Liu H
    Acta Biochim Biophys Sin (Shanghai); 2022 Nov; 54(11):1731-1739. PubMed ID: 36514219
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oncogene-induced Nrf2 transcription promotes ROS detoxification and tumorigenesis.
    DeNicola GM; Karreth FA; Humpton TJ; Gopinathan A; Wei C; Frese K; Mangal D; Yu KH; Yeo CJ; Calhoun ES; Scrimieri F; Winter JM; Hruban RH; Iacobuzio-Donahue C; Kern SE; Blair IA; Tuveson DA
    Nature; 2011 Jul; 475(7354):106-9. PubMed ID: 21734707
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The ROS-KRAS-Nrf2 axis in the control of the redox homeostasis and the intersection with survival-apoptosis pathways: Implications for photodynamic therapy.
    Ferino A; Rapozzi V; Xodo LE
    J Photochem Photobiol B; 2020 Jan; 202():111672. PubMed ID: 31778952
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.